HR 2829 RFS 
ensuring that such information is shared among 
law enforcement agencies and with the high in-
tensity drug trafficking area; 
‘‘(F) the nature and extent to which infor-
mation sharing and enforcement activities are 
coordinated with joint terrorism task forces in 
the high intensity drug trafficking area; and 
‘‘(G) any recommendations for measures 
needed to ensure that task force resources are 
utilized efficiently and effectively to reduce the 
availability of illegal drugs in the high intensity 
drug trafficking areas. 
‘‘(m) ASSESSMENT OF INTELLIGENCE SHARING IN 
HIGH
INTENSITY
DRUG
TRAFFICKING
AREAS—PRO-
GRAM.—Not later than 180 days after the date of the en-
actment of this subsection, and as part of each subsequent 
annual National Drug Control Strategy report, the Direc-
tor, in consultation with the Director of National Intel-
ligence, shall submit to Congress a report— 
‘‘(1) evaluating existing and planned intel-
ligence systems supported by each high intensity 
drug trafficking area, or utilized by task forces re-
ceiving any funding under the Program, including 
the extent to which such systems ensure access and 
availability of intelligence to Federal, State, and 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00065
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
local law enforcement agencies within the high inten-
sity drug trafficking area and outside of it; 
‘‘(2) the extent to which Federal, State, and 
local law enforcement agencies participating in each 
high intensity drug trafficking area are sharing in-
telligence information to assess current drug traf-
ficking threats and design appropriate enforcement 
strategies; and 
‘‘(3) the measures needed to improve effective 
sharing of information and intelligence regarding 
drug trafficking and drug production among Fed-
eral, State, and local law enforcement participating 
in a high intensity drug trafficking area, and be-
tween such agencies and similar agencies outside the 
high intensity drug trafficking area. 
‘‘(n) COORDINATION
OF INTELLIGENCE SHARING 
WITH ORGANIZED CRIME DRUG ENFORCEMENT TASK 
FORCE PROGRAM.—The Director, in consultation with the 
Attorney General, shall ensure that any drug enforcement 
intelligence obtained by the Intelligence Support Center 
for each high intensity drug trafficking area is shared, on 
a timely basis, with the drug intelligence fusion center op-
erated by the Organized Crime Drug Enforcement Task 
Force of the Department of Justice. 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00066
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(o) USE OF FUNDS TO COMBAT METHAMPHET-
AMINE TRAFFICKING.— 
‘‘(1) IN GENERAL.— 
‘‘(A) REQUIREMENT.—The Director shall 
ensure that, of the amounts appropriated for a 
fiscal 
year 
for 
the 
Program, 
at 
least 
$15,000,000 is allocated to combat the traf-
ficking of methamphetamine in areas des-
ignated by the Director as high intensity drug 
trafficking areas. 
‘‘(B) ACTIVITIES.—In meeting the require-
ment in subparagraph (A), the Director shall 
transfer funds to appropriate Federal, State, 
and local governmental agencies for employing 
additional Federal law enforcement personnel, 
or facilitating the employment of additional 
State and local law enforcement personnel, in-
cluding agents, investigators, prosecutors, lab-
oratory technicians, chemists, investigative as-
sistants, and drug prevention specialists. 
‘‘(2) APPORTIONMENT OF FUNDS.— 
‘‘(A) FACTORS IN APPORTIONMENT.—The 
Director shall apportion amounts allocated 
under paragraph (1) among areas designated by 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00067
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
the Director as high intensity drug trafficking 
areas based on the following factors: 
‘‘(i) The number of methamphetamine 
manufacturing facilities discovered by Fed-
eral, State, or local law enforcement offi-
cials in the area during the previous fiscal 
year. 
‘‘(ii) The number of methamphet-
amine prosecutions in Federal, State, or 
local courts in the area during the previous 
fiscal year. 
‘‘(iii) The number of methamphet-
amine arrests by Federal, State, or local 
law enforcement officials in the area dur-
ing the previous fiscal year. 
‘‘(iv) The amounts of methamphet-
amine or listed chemicals (as that term is 
defined in section 102(33) of the Con-
trolled 
Substances 
Act 
(21 
U.S.C. 
802(33)) seized by Federal, State, or local 
law enforcement officials in the area dur-
ing the previous fiscal year. 
‘‘(v) Intelligence and predictive data 
from the Drug Enforcement Administra-
tion showing patterns and trends in abuse, 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00068
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
trafficking, and transportation in meth-
amphetamine and listed chemicals (as that 
term is so defined). 
‘‘(B) CERTIFICATION.—Before the Direc-
tor apportions any funds under this paragraph 
to a high intensity drug trafficking area, the 
Director shall certify that the law enforcement 
entities responsible for clandestine methamphet-
amine laboratory seizures in that area are pro-
viding laboratory seizure data to the national 
clandestine laboratory database at the El Paso 
Intelligence Center. 
‘‘(p) AUTHORIZATION OF APPROPRIATIONS.—There 
is authorized to be appropriated to the Office of National 
Drug Control Policy to carry out this section— 
‘‘(1) $280,000,000 for fiscal year 2007; 
‘‘(2) $290,000,000 for each of fiscal years 2008 
and 2009; and 
‘‘(3) $300,000,000 for each of fiscal years 2010 
and 2011.’’. 
SEC. 10. FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS. 
(a) SHORT TITLE.—This section may be cited as the 
‘‘Dawson Family Community Protection Act’’. 
(b) FINDINGS.—Congress finds the following: 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00069
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
(1) In the early morning hours of October 16, 
2002, the home of Carnell and Angela Dawson was 
firebombed 
in 
apparent 
retaliation 
for 
Mrs. 
Dawson’s notification of police about persistent drug 
distribution activity in their East Baltimore City 
neighborhood. 
(2) The arson claimed the lives of Mr. and Mrs. 
Dawson and their 5 young children, aged 9 to 14. 
(3) The horrific murder of the Dawson family 
is a stark example of domestic narco-terrorism. 
(4) In all phases of counter-narcotics law en-
forcement—from prevention to investigation to pros-
ecution to reentry—the voluntary cooperation of or-
dinary citizens is a critical component. 
(5) Voluntary cooperation is difficult for law en-
forcement officials to obtain when citizens feel that 
cooperation carries the risk of violent retaliation by 
illegal drug trafficking organizations and their affili-
ates. 
(6) Public confidence that law enforcement is 
doing all it can to make communities safe is a pre-
requisite for voluntary cooperation among people 
who may be subject to intimidation or reprisal (or 
both). 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00070
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
(7) Witness protection programs are insufficient 
on their own to provide security because many indi-
viduals and families who strive every day to make 
distressed neighborhoods livable for their children, 
other relatives, and neighbors will resist or refuse of-
fers of relocation by local, State, and Federal pros-
ecutorial agencies and because, moreover, the contin-
ued presence of strong individuals and families is 
critical to preserving and strengthening the social 
fabric in such communities. 
(8) Where (as in certain sections of Baltimore 
City) interstate trafficking of illegal drugs has severe 
ancillary local consequences within areas designated 
as high intensity drug trafficking areas, it is impor-
tant that supplementary High Intensity Drug Traf-
ficking Areas Program funds be committed to sup-
port initiatives aimed at making the affected com-
munities safe for the residents of those communities 
and encouraging their cooperation with local, State, 
and Federal law enforcement efforts to combat ille-
gal drug trafficking. 
(c) FUNDING FOR CERTAIN HIGH INTENSITY DRUG 
TRAFFICKING AREAS.—Section 707 (21 U.S.C. 1706), as 
amended by section 9, is further amended by adding at 
the end the following new subsection: 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00071
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(q) SPECIFIC PURPOSES.— 
‘‘(1) IN GENERAL.—The Director shall ensure 
that, of the amounts appropriated for a fiscal year 
for the Program, at least $7,000,000 is used in high 
intensity drug trafficking areas with severe neigh-
borhood safety and illegal drug distribution prob-
lems. 
‘‘(2) REQUIRED USES.—The funds used under 
paragraph (1) shall be used— 
‘‘(A) to ensure the safety of neighborhoods 
and the protection of communities, including 
the prevention of the intimidation of potential 
witnesses of illegal drug distribution and related 
activities; and 
‘‘(B) to combat illegal drug trafficking 
through such methods as the Director considers 
appropriate, such as establishing or operating 
(or both) a toll-free telephone hotline for use by 
the public to provide information about illegal 
drug-related activities.’’. 
SEC. 11. AMENDMENTS RELATING TO COUNTER-DRUG 
TECHNOLOGY ASSESSMENT CENTER. 
(a) CHIEF SCIENTIST.—Section 708(b) (21 U.S.C. 
1707(b)) is amended— 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00072
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
(1) in the heading by striking ‘‘DIRECTOR OF 
TECHNOLOGY.—’’ 
and 
inserting 
‘‘CHIEF
SCI-
ENTIST.—’’; and 
(2) by striking ‘‘Director of Technology,’’ and 
inserting ‘‘Chief Scientist,’’. 
(b) ADDITIONAL RESPONSIBILITIES OF DIRECTOR.— 
Section 708(c) (21 U.S.C. 1707(c)) is amended to read 
as follows: 
‘‘(c) ADDITIONAL RESPONSIBILITIES OF THE DIREC-
TOR OF NATIONAL DRUG CONTROL POLICY.— 
‘‘(1) 
IN
GENERAL.—The 
Director, 
acting 
through the Chief Scientist shall— 
‘‘(A) identify and define the short-, me-
dium-, and long-term scientific and techno-
logical needs of Federal, State, and local law 
enforcement agencies relating to drug enforce-
ment, including— 
‘‘(i) advanced surveillance, tracking, 
and radar imaging; 
‘‘(ii) electronic support measures; 
‘‘(iii) communications; 
‘‘(iv) data fusion, advanced computer 
systems, and artificial intelligence; and 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00073
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(v) chemical, biological, radiological 
(including neutron, electron, and graviton), 
and other means of detection; 
‘‘(B) identify demand reduction (including 
drug prevention) basic and applied research 
needs and initiatives, in consultation with af-
fected National Drug Control Program agen-
cies, including— 
‘‘(i) improving treatment through 
neuroscientific advances; 
‘‘(ii) improving the transfer of bio-
medical research to the clinical setting; and 
‘‘(iii) in consultation with the Na-
tional Institute on Drug Abuse and the 
Substance Abuse and Mental Health Serv-
ices Administration, and through inter-
agency agreements or grants, examining 
addiction and rehabilitation research and 
the application of technology to expanding 
the effectiveness or availability of drug 
treatment; 
‘‘(C) make a priority ranking of such needs 
identified in subparagraphs (A) and (B) accord-
ing to fiscal and technological feasibility, as 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00074
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
part of a National Counterdrug Research and 
Development Program; 
‘‘(D) oversee and coordinate counterdrug 
technology initiatives with related activities of 
other Federal civilian and military departments; 
‘‘(E) provide support to the development 
and implementation of the national drug control 
performance measurement system established 
under subsection (b) of section 706; 
‘‘(F) with the advice and counsel of experts 
from State and local law enforcement agencies, 
oversee and coordinate a technology transfer 
program for the transfer of technology to State 
and local law enforcement agencies; and 
‘‘(G) pursuant to the authority of the Di-
rector of National Drug Control Policy under 
section 704, submit requests to Congress for 
the reprogramming or transfer of funds appro-
priated for counterdrug technology research and 
development. 
‘‘(2) PRIORITIES
IN
TRANSFERRING
TECH-
NOLOGY.— 
‘‘(A) IN
GENERAL.—The Chief Scientist 
shall give priority, in transferring technology 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00075
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
under paragraph (1)(F), based on the following 
criteria: 
‘‘(i) the need of potential recipients 
for such technology; 
‘‘(ii) the effectiveness of the tech-
nology to enhance current counterdrug ac-
tivities of potential recipients; and 
‘‘(iii) the ability and willingness of po-
tential recipients to evaluate transferred 
technology. 
‘‘(B) INTERDICTION
AND
BORDER
DRUG 
LAW
ENFORCEMENT
TECHNOLOGIES.—The 
Chief Scientist shall give priority, in transfer-
ring technologies most likely to assist in drug 
interdiction and border drug law enforcement, 
to State, local, and tribal law enforcement agen-
cies in southwest border areas and northern 
border areas with significant traffic in illicit 
drugs. 
‘‘(3) LIMITATION ON AUTHORITY.—The author-
ity granted to the Director under this subsection 
shall not extend to the direct management of indi-
vidual projects or other operational activities. 
‘‘(4) REPORT.—On or before July 1 of each 
year, the Director shall submit a report to the ap-
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00076
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
propriate congressional committees that addresses 
the following: 
‘‘(A) The number of requests received dur-
ing the previous 12 months, including the iden-
tity of each requesting agency and the type of 
technology requested. 
‘‘(B) The number of requests fulfilled dur-
ing the previous 12 months, including the iden-
tity of each recipient agency and the type of 
technology transferred. 
‘‘(C) A summary of the criteria used in 
making the determination on what requests 
were funded and what requests were not fund-
ed, except that such summary shall not include 
specific information on any individual requests. 
‘‘(D) A general assessment of the future 
needs of the program, based on expected 
changes in threats, expected technologies, and 
likely need from potential recipients. 
‘‘(E) An assessment of the effectiveness of 
the technologies transferred, based in part on 
the evaluations provided by the recipients, with 
a recommendation whether the technology 
should continue to be offered through the pro-
gram.’’. 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00077
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
(c) ASSISTANCE FROM SECRETARY OF HOMELAND 
SECURITY.—Section 708(d) (21 U.S.C. 1707(d)) is 
amended by inserting ‘‘, the Secretary of Homeland Secu-
rity,’’ after ‘‘The Secretary of Defense’’. 
SEC. 12. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
(a) IN GENERAL.—Section 709 (21 U.S.C. 1708) is 
amended to read as follows: 
‘‘SEC. 709. NATIONAL YOUTH ANTIDRUG MEDIA CAMPAIGN. 
‘‘(a) IN GENERAL.—The Director shall conduct a na-
tional youth anti-drug media campaign (referred to in this 
subtitle as the ‘national media campaign’) in accordance 
with this section for the purposes of— 
‘‘(1) preventing drug abuse among young peo-
ple in the United States; 
‘‘(2) increasing awareness of adults of the im-
pact of drug abuse on young people; and 
‘‘(3) encouraging parents and other interested 
adults to discuss with young people the dangers of 
illegal drug use. 
‘‘(b) USE OF FUNDS.— 
‘‘(1) IN GENERAL.—Amounts made available to 
carry out this section for the national media cam-
paign may only be used for the following: 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00078
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(A) The purchase of media time and 
space, including the strategic planning for, and 
accounting of, such purchases. 
‘‘(B) Creative and talent costs, consistent 
with paragraph (2)(A). 
‘‘(C) Advertising production costs. 
‘‘(D) Testing and evaluation of advertising. 
‘‘(E) Evaluation of the effectiveness of the 
national media campaign. 
‘‘(F) The negotiated fees for the winning 
bidder on requests for proposals issued either 
by the Office or its designee to enter into con-
tracts to carry out activities authorized by this 
section. 
‘‘(G) Partnerships with professional and 
civic groups, community-based organizations, 
including faith-based organizations, and govern-
ment organizations related to the national 
media campaign. 
‘‘(H) Entertainment industry outreach, 
interactive outreach, media projects and activi-
ties, public information, news media outreach, 
and corporate sponsorship and participation. 
‘‘(I) Operational and management ex-
penses. 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00079
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
‘‘(2) SPECIFIC REQUIREMENTS.— 
‘‘(A) CREATIVE SERVICES.— 
‘‘(i) In using amounts for creative and 
talent costs under paragraph (1)(B), the 
Director shall use creative services donated 
at no cost to the Government (including 
creative services provided by the Partner-
ship for a Drug-Free America) wherever 
feasible and may only procure creative 
services for advertising— 
‘‘(I) responding to high-priority 
or emergent campaign needs that can-
not timely be obtained at no cost; or 
‘‘(II) intended to reach a minor-
ity, ethnic, or other special audience 
that cannot reasonably be obtained at 
no cost; or 
‘‘(III) the Director determines 
that the Partnership for a Drug-Free 
America is unable to provide, pursu-
ant to subsection (d)(2)(B). 
‘‘(ii) Subject to the availability of ap-
propriations, no more than $1,500,000 
may be expended under this section each 
fiscal year on creative services, except that 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00080
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
the Director may expend up to $2,000,000 
in a fiscal year on creative services to meet 
urgent needs of the national media cam-
paign with advance approval from the 
Committee on Appropriations of the House 
of Representatives and of the Senate upon 
a showing of the circumstances causing 
such urgent needs of the national media 
campaign. 
‘‘(B) TESTING AND EVALUATION OF AD-
VERTISING.—In using amounts for testing and 
evaluation of advertising under paragraph 
(1)(D), the Director shall test all advertise-
ments prior to use in the national media cam-
paign to ensure that the advertisements are ef-
fective and meet industry-accepted standards. 
The Director may waive this requirement for 
advertisements using no more than 10 percent 
of the purchase of advertising time purchased 
under this section in a fiscal year and no more 
than 10 percent of the advertising space pur-
chased under this section in a fiscal year, if the 
advertisements respond to emergent and time- 
sensitive campaign needs or the advertisements 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00081
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS
HR 2829 RFS 
will not be widely utilized in the national media 
campaign. 
‘‘(C) EVALUATION OF EFFECTIVENESS OF 
MEDIA CAMPAIGN.—In using amounts for the 
evaluation of the effectiveness of the national 
media campaign under paragraph (1)(E), the 
Director shall— 
‘‘(i) designate an independent entity 
to evaluate annually the effectiveness of 
the national media campaign based on 
data from— 
‘‘(I) the Monitoring the Future 
Study published by the Department of 
Health and Human Services; 
‘‘(II) 
the 
Attitude 
Tracking 
Study published by the Partnership 
for a Drug Free America; 
‘‘(III) the National Household 
Survey on Drug Abuse; and 
‘‘(IV) other relevant studies or 
publications, as determined by the Di-
rector, including tracking and evalua-
tion data collected according to mar-
keting and advertising industry stand-
ards; and 
VerDate Aug 31 2005 
22:16 Mar 13, 2006
Jkt 049200
PO 00000
Frm 00082
Fmt 6652
Sfmt 6201
E:\BILLS\H2829.RFS
H2829
sroberts on PROD1PC70 with BILLS